Summary of medicine characteristics - CHILDRENS 3 MONTHS PLUS SIMPLE COUGH LINCTUS, INFANT SUGAR FREE SIMPLE COUGH LINCTUS, BOOTS COUGH SYRUP 3 MONTHS PLUS, INFANT SIMPLE COUGH LINCTUS 3 MONTHS PLUS
1 NAME OF THE MEDICINAL PRODUCT
Infant Simple Cough Linctus 3 Months Plus or Infant Sugar Free Simple Cough Linctus or Children's 3 Months Plus Simple Cough Linctus or Boots Cough Syrup 3 Months Plus.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Syrup
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
For the relief of dry tickly coughs.
4.2 Posology and Method of Administration
For oral administration.
Children 3 months – 1 year:
Children 1 to 5 years:
Children under 3 months:
one 5ml spoonful three to four times a day. two 5ml spoonfuls three to four times a day. not recommended.
4.3 Contra-Indications
Hypersensitivity to any of the ingredients.
Not recommended for children under 3 months.
If symptoms persist for more than 3 days consult your doctor.
Keep all medicines out of the reach of children.
4.5 Interactions with other Medicinal Products and other Forms of Interaction
No clinically significant drug interactions.
4.6 Pregnancy and Lactation
The safety of this product during pregnancy and lactation has not been established but is not thought to constitute a hazard.
4.7 Effects on Ability to Drive and Use Machines
No adverse effects known.
4.8 Undesirable effects
Immune system disorder: hypersensitivity reactions, including anaphylaxis.
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
4.9 Overdose
4.9 OverdoseOverdosage with this product may possibly cause diarrhoea. Treatment should be symptomatic.
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
Glycerin has demulcent properties and may possibly block sensory cough receptors in the respiratory tract.
5.2 Pharmacokinetic Properties
None stated.
5.3 Pre-clinical Safety Data
5.3 Pre-clinical Safety DataNot applicable.
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Maltitol liquid
Hydroxyethylcellulose
Sodium Benzoate
Citric Acid Monohydrate
Sodium Citrate
Apple flavouring 5112OIE
Purified Water
6.2 Incompatibilities
None stated.
6.3 Shelf-Life
36 months.
Do not store above 25°C. Keep tightly closed.
6.5 Nature and Content of Container
1) Bottle amber PET with polypropylene child resistant closure fitted with expanded polythene liner.
Pack size: 150 ml, 100ml
2) Bottle amber glass with polypropylene child resistant closure fitted with an expanded polyethylene liner.
Pack size 100, 125 or 150ml.
6.6 Instructions for Use, Handling and Disposal
6.6 Instructions for Use, Handling and DisposalNot applicable.
7 MARKETING AUTHORISATION HOLDER
The Boots Company PLC
1 Thane Road West
Nottingham
NG2 3AA
Trading as: BCM
8 MARKETING AUTHORISATION NUMBER(S)
PL 00014/0500